Brief: Revive Therapeutics Announces Approval Of CSE Listing
19/07/2019 15:37
July 19 (Reuters) - Revive Therapeutics Ltd RVV.V :
* REVIVE THERAPEUTICS ANNOUNCES APPROVAL OF CSE LISTING AND
DELISTING FROM TSX-V
* REVIVE THERAPEUTICS LTD - CO RECEIVED FINAL APPROVAL TO
LIST ITS
COMMON SHARES ON CANADIAN SECURITIES EXCHANGE
* REVIVE THERAPEUTICS LTD - DE-LISTING OF COMMON SHARES FROM
TSX-V
IS EXPECTED TO BECOME EFFECTIVE AFTER MARKET CLOSE ON JULY 22,
2019
* REVIVE THERAPEUTICS LTD - COMMON SHARES WILL COMMENCE
TRADING ON
CSE AT MARKET OPENING ON JULY 23, 2019
Source text for Eikon: ID:nGNX3nrkn5
Further company coverage: RVV.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revive Therapeutics
See all newsBrief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Announces Closing Of Second Tranche Of Private Placement
Brief: Revive Therapeutics Nears Completion Of Key Nerve Agent Countermeasure Study With Canadian Department Of National Defence
Brief: Revive Therapeutics Provides Update On Research Study Evaluating Bucillamine For Nerve Agent Exposure